What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

1. Effects of TP regimen combined with intraperitoneal hyperthermic perfusion chemotherapy on immune function, quality of life and prognosis of patients with advanced ovarian cancer.American journal of translational research · 2024
   Article
2. Diagnostic value of serum CA125 combined with PET/CT in ovarian cancer and tuberculous peritonitis in female patients.Abdominal radiology (New York) · 2023
   Article
3. Role of Artificial Intelligence and Machine Learning in Prediction, Diagnosis, and Prognosis of Cancer.Cureus · 2022
   Review
4. Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report.Case reports in oncology
   Article
5. Safety and Efficacy of the Metabolic Profiling of the BIMRT Utilizing 18F FDG PET-CT.Technology in cancer research & treatment
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as